Abstract
The DJ-1 protein was originally linked with Parkinson’s disease and is now known to have antioxidant functions. The protein has three redox-sensitive cysteine residues, which are involved in its dimerisation and functional properties. A mildly oxidised form of DJ-1 is the most active form and protects cells from oxidative stress conditions. DJ-1 functions as an antioxidant through a variety of mechanisms, including a weak direct antioxidant activity by scavenging reactive oxygen species. DJ-1 also regulates a number of signalling pathways, including the inhibition of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis under oxidative stress conditions. Other proteins regulated by DJ-1 include enzymes, chaperones, the 20S proteasome and transcription factors, including Nrf2. Once activated by oxidative stress, Nrf2 upregulates antioxidant gene expression including members of the thioredoxin and glutathione pathways, which in turn mediate an antioxidant protective function. Crosstalk between DJ-1 and both the thioredoxin and glutathione systems has also been identified. Thioredoxin reduces a cysteine residue on DJ-1 to modulate its activity, while glutaredoxin1 de-glutathionylates DJ-1, preventing degradation of DJ-1 and resulting in its accumulation. DJ-1 also regulates the activity of glutamate cysteine ligase, which is the rate-limiting step for glutathione synthesis. These antioxidant functions of DJ-1 are key to its role in protecting neurons from oxidative stress and are hypothesised to protect the brain from the development of neurodegenerative diseases such as Parkinson’s disease (PD) and to protect cardiac tissues from ischaemic-reperfusion injury. However, DJ-1, as an antioxidant, also protects cancer cells from undergoing oxidative stress-induced apoptosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andres-Mateos E, Perier C, Zhang L, Blanchard-Fillion B, Greco TM, Thomas B, Ko HS, Sasaki M, Ischiropoulos H, Przedborski S, Dawson TM, Dawson VL (2007) DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc Natl Acad Sci U S A 104(37):14807–14812. https://doi.org/10.1073/pnas.0703219104
Ariga H, Takahashi-Niki K, Kato I, Maita H, Niki T, Iguchi-Ariga SM (2013) Neuroprotective function of DJ-1 in Parkinson’s disease. Oxidative Med Cell Longev 2013:683920. https://doi.org/10.1155/2013/683920
Arner ES, Holmgren A (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267(20):6102–6109
Blackinton J, Lakshminarasimhan M, Thomas KJ, Ahmad R, Greggio E, Raza AS, Cookson MR, Wilson MA (2009) Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J Biol Chem 284(10):6476–6485. https://doi.org/10.1074/jbc.M806599200
Callio J, Oury TD, Chu CT (2005) Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains. J Biol Chem 280(18):18536–18542. https://doi.org/10.1074/jbc.M413224200
Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S, Baptista MJ, Ringe D, Petsko GA, Cookson MR (2004) The Parkinson’s disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 101(24):9103–9108. https://doi.org/10.1073/pnas.0402959101
Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1 alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 275(33):25130–25138. https://doi.org/10.1074/jbc.M001914200
Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281(5384):1860–1863
Choi J, Sullards MC, Olzmann JA, Rees HD, Weintraub ST, Bostwick DE, Gearing M, Levey AI, Chin LS, Li L (2006) Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 281(16):10816–10824. https://doi.org/10.1074/jbc.M509079200
Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP (2006) DJ-1, a cancer- and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A 103(41):15091–15096. https://doi.org/10.1073/pnas.0607260103
Cuevas S, Yang Y, Konkalmatt P, Asico LD, Feranil J, Jones J, Villar VA, Armando I, Jose PA (2015) Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1. Hypertension 65(6):1251–1257. https://doi.org/10.1161/HYPERTENSIONAHA.114.04525
Das KC, Das CK (2000) Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions. Biochem Biophys Res Commun 277(2):443–447. https://doi.org/10.1006/bbrc.2000.3689
Dumont M, Beal MF (2011) Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med 51(5):1014–1026. https://doi.org/10.1016/j.freeradbiomed.2010.11.026
Eltoweissy M, Muller GA, Bibi A, Nguye PV, Dihazi GH, Muller CA, Dihazi H (2011) Proteomics analysis identifies PARK7 as an important player for renal cell resistance and survival under oxidative stress. Mol BioSyst 7(4):1277–1288. https://doi.org/10.1039/c0mb00116c
Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K, Poellinger L, Fujii-Kuriyama Y (1999) Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J 18(7):1905–1914. https://doi.org/10.1093/emboj/18.7.1905
Fan J, Ren H, Jia N, Fei E, Zhou T, Jiang P, Wu M, Wang G (2008) DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem 283(7):4022–4030. https://doi.org/10.1074/jbc.M707176200
Fernandes AP, Holmgren A (2004) Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6(1):63–74. https://doi.org/10.1089/152308604771978354
Fernandez-Caggiano M, Schroder E, Cho HJ, Burgoyne J, Barallobre-Barreiro J, Mayr M, Eaton P (2016) Oxidant-induced Interprotein disulfide formation in cardiac protein DJ-1 occurs via an interaction with Peroxiredoxin 2. J Biol Chem 291(19):10399–10410. https://doi.org/10.1074/jbc.M115.699850
Floor E, Wetzel MG (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem 70(1):268–275
Fu C, Wu C, Liu T, Ago T, Zhai P, Sadoshima J, Li H (2009) Elucidation of thioredoxin target protein networks in mouse. Mol Cell Proteomics 8(7):1674–1687. https://doi.org/10.1074/mcp.M800580-MCP200
Gan L, Johnson DA, Johnson JA (2010) Keap1-Nrf2 Activation in the presence and absence of DJ-1. Eur J Neurosci 31(6):967–977. https://doi.org/10.1111/j.1460-9568.2010.07138.x
Girotto S, Sturlese M, Bellanda M, Tessari I, Cappellini R, Bisaglia M, Bubacco L, Mammi S (2012) Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53. J Biol Chem 287(22):18738–18749. https://doi.org/10.1074/jbc.M111.311589
Go YM, Roede JR, Walker DI, Duong DM, Seyfried NT, Orr M, Liang Y, Pennell KD, Jones DP (2013) Selective targeting of the cysteine proteome by thioredoxin and glutathione redox systems. Mol Cell Proteomics 12(11):3285–3296. https://doi.org/10.1074/mcp.M113.030437
Goldberg JA, Guzman JN, Estep CM, Ilijic E, Kondapalli J, Sanchez-Padilla J, Surmeier DJ (2012) Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson’s disease. Nat Neurosci 15(10):1414–1421. https://doi.org/10.1038/nn.3209
Hayes JD, Dinkova-Kostova AT (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39(4):199–218. https://doi.org/10.1016/j.tibs.2014.02.002
He T, Banach-Latapy A, Vernis L, Dardalhon M, Chanet R, Huang ME (2013) Peroxiredoxin 1 knockdown potentiates beta-lapachone cytotoxicity through modulation of reactive oxygen species and mitogen-activated protein kinase signals. Carcinogenesis 34(4):760–769. https://doi.org/10.1093/carcin/bgs389
Holmgren A (1985) Thioredoxin. Annu Rev Biochem 54:237–271. https://doi.org/10.1146/annurev.bi.54.070185.001321
Honbou K, Suzuki NN, Horiuchi M, Niki T, Taira T, Ariga H, Inagaki F (2003) The crystal structure of DJ-1, a protein related to male fertility and Parkinson’s disease. J Biol Chem 278(33):31380–31384. https://doi.org/10.1074/jbc.M305878200
Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275(5296):90–94
Im JY, Lee KW, Junn E, Mouradian MM (2010) DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex. Neurosci Res 67(3):203–208. https://doi.org/10.1016/j.neures.2010.04.002
Im JY, Lee KW, Woo JM, Junn E, Mouradian MM (2012) DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum Mol Genet 21(13):3013–3024. https://doi.org/10.1093/hmg/dds131
Ismail IA, Kang HS, Lee HJ, Kwon BM, Hong SH (2012) 2′-Benzoyloxycinnamaldehyde-mediated DJ-1 upregulation protects MCF-7 cells from mitochondrial damage. Biol Pharm Bull 35(6):895–902
Ismail IA, Abdel Shakor AB, Hong SH (2015) DJ-1 protects breast cancer cells against 2′-Benzoyloxycinnamaldehyde-induced oxidative stress independent of Nrf2. J Cell Physiol 230(9):2262–2269. https://doi.org/10.1002/jcp.24957
Ito G, Ariga H, Nakagawa Y, Iwatsubo T (2006) Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1. Biochem Biophys Res Commun 339(2):667–672. https://doi.org/10.1016/j.bbrc.2005.11.058
Jenner P, Olanow CW (2006) The pathogenesis of cell death in Parkinson’s disease. Neurology 66(10 Suppl 4):S24–S36
Johnson WM, Wilson-Delfosse AL, Mieyal JJ (2012) Dysregulation of glutathione homeostasis in neurodegenerative diseases. Forum Nutr 4(10):1399–1440. https://doi.org/10.3390/nu4101399
Johnson WM, Golczak M, Choe K, Currran PL, Gorelenkova Miller O, Yao C, Wang W, Lin J, Milkovic NM, Ray A, Ravindranath V, Zhu X, Wilson MA, Wilson-Delfosse AL, Chen SG, Mieyal JJ (2016) Regulation of DJ-1 by glutaredoxin 1 in vivo – implications for Parkinson’s disease. Biochemistry. https://doi.org/10.1021/acs.biochem.5b01132
Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, Mouradian MM (2005) Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci U S A 102(27):9691–9696. https://doi.org/10.1073/pnas.0409635102
Kim SJ, Miyoshi Y, Taguchi T, Tamaki Y, Nakamura H, Yodoi J, Kato K, Noguchi S (2005a) High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin Cancer Res 11(23):8425–8430. https://doi.org/10.1158/1078-0432.CCR-05-0449
Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, DeLuca C, Liepa J, Zhou L, Snow B, Binari RC, Manoukian AS, Bray MR, Liu FF, Tsao MS, Mak TW (2005b) DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7(3):263–273. https://doi.org/10.1016/j.ccr.2005.02.010
Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW (2005c) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A 102(14):5215–5220. https://doi.org/10.1073/pnas.0501282102
Kim YC, Kitaura H, Taira T, Iguchi-Ariga SM, Ariga H (2009) Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. Int J Oncol 35(6):1331–1341
Kim SJ, Park YJ, Hwang IY, Youdim MB, Park KS, YJ O (2012a) Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death. Free Radic Biol Med 53(4):936–950. https://doi.org/10.1016/j.freeradbiomed.2012.05.035
Kim SJ, Park YJ, YJ O (2012b) Proteomic analysis reveals a protective role for DJ-1 during 6-hydroxydopamine-induced cell death. Biochem Biophys Res Commun 422(1):8–14. https://doi.org/10.1016/j.bbrc.2012.04.063
Kinumi T, Kimata J, Taira T, Ariga H, Niki E (2004) Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun 317(3):722–728. https://doi.org/10.1016/j.bbrc.2004.03.110
Le Moan N, Clement G, Le Maout S, Tacnet F, Toledano MB (2006) The Saccharomyces Cerevisiae proteome of oxidized protein thiols: contrasted functions for the thioredoxin and glutathione pathways. J Biol Chem 281(15):10420–10430. https://doi.org/10.1074/jbc.M513346200
Lev N, Ickowicz D, Melamed E, Offen D (2008) Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. Neurotoxicology 29(3):397–405. https://doi.org/10.1016/j.neuro.2008.01.007
Lev N, Ickowicz D, Barhum Y, Lev S, Melamed E, Offen D (2009) DJ-1 protects against dopamine toxicity. J Neural Transm 116(2):151–160. https://doi.org/10.1007/s00702-008-0134-4
Li C, Thompson MA, Tamayo AT, Zuo Z, Lee J, Vega F, Ford RJ, Pham LV (2012) Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma. Oncotarget 3(3):314–326. 10.18632/oncotarget.463
Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM (2003) The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res 23(3B):2425–2433
Liu H, Wang M, Li M, Wang D, Rao Q, Wang Y, Xu Z, Wang J (2008) Expression and role of DJ-1 in leukemia. Biochem Biophys Res Commun 375(3):477–483. https://doi.org/10.1016/j.bbrc.2008.08.046
Lu J, Holmgren A (2014) The thioredoxin antioxidant system. Free Radic Biol Med 66:75–87. https://doi.org/10.1016/j.freeradbiomed.2013.07.036
Lu HS, Chen HP, Wang S, Yu HH, Huang XS, Huang QR, He M (2012) Hypoxic preconditioning up-regulates DJ-1 protein expression in rat heart-derived H9c2 cells through the activation of extracellular-regulated kinase 1/2 pathway. Mol Cell Biochem 370(1–2):231–240. https://doi.org/10.1007/s11010-012-1414-8
Lushchak VI (2012) Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids 2012:736837. https://doi.org/10.1155/2012/736837
MacKeigan JP, Clements CM, Lich JD, Pope RM, Hod Y, Ting JP (2003) Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res 63(20):6928–6934
Mahmood DF, Abderrazak A, El Hadri K, Simmet T, Rouis M (2013) The thioredoxin system as a therapeutic target in human health and disease. Antioxid Redox Signal 19(11):1266–1303. https://doi.org/10.1089/ars.2012.4757
Mani M, Khaghani S, Gol Mohammadi T, Zamani Z, Azadmanesh K, Meshkani R, Pasalar P, Mostafavi E (2013) Activation of Nrf2-antioxidant response element mediated glutamate cysteine ligase expression in hepatoma cell line by homocysteine. Hepat Mon 13(5):e8394. https://doi.org/10.5812/hepatmon.8394
Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT (1992) Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20(15):3821–3830
McNally RS, Davis BK, Clements CM, Accavitti-Loper MA, Mak TW, Ting JP (2011) DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB. J Biol Chem 286(6):4098–4106. https://doi.org/10.1074/jbc.M110.147371
Meuillet EJ, Mahadevan D, Berggren M, Coon A, Powis G (2004) Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN’s lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN’s tumor suppressor activity. Arch Biochem Biophys 429(2):123–133. https://doi.org/10.1016/j.abb.2004.04.020
Michiels C (2004) Physiological and pathological responses to hypoxia. Am J Pathol 164(6):1875–1882. https://doi.org/10.1016/S0002-9440(10)63747-9
Mo JS, Jung J, Yoon JH, Hong JA, Kim MY, Ann EJ, Seo MS, Choi YH, Park HS (2010) DJ-1 modulates the p38 mitogen-activated protein kinase pathway through physical interaction with apoptosis signal-regulating kinase 1. J Cell Biochem 110(1):229–237. https://doi.org/10.1002/jcb.22530
Moscovitz O, Ben-Nissan G, Fainer I, Pollack D, Mizrachi L, Sharon M (2015) The Parkinson’s-associated protein DJ-1 regulates the 20S proteasome. Nat Commun 6:6609. https://doi.org/10.1038/ncomms7609
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74(5):1124–1136
Nerini-Molteni S, Ferrarini M, Cozza S, Caligaris-Cappio F, Sitia R (2008) Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib. Br J Haematol 141(4):494–503. https://doi.org/10.1111/j.1365-2141.2008.07066.x
Nordberg J, Arner ES (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31(11):1287–1312
Park JH, Kim YS, Lee HL, Shim JY, Lee KS, YJ O, Shin SS, Choi YH, Park KJ, Park RW, Hwang SC (2006) Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 11(3):269–275. https://doi.org/10.1111/j.1440-1843.2006.00849.x
Parsanejad M, Bourquard N, Qu D, Zhang Y, Huang E, Rousseaux MW, Aleyasin H, Irrcher I, Callaghan S, Vaillant DC, Kim RH, Slack RS, Mak TW, Reddy ST, Figeys D, Park DS (2014a) DJ-1 interacts with and regulates paraoxonase-2, an enzyme critical for neuronal survival in response to oxidative stress. PLoS One 9(9):e106601. https://doi.org/10.1371/journal.pone.0106601
Parsanejad M, Zhang Y, Qu D, Irrcher I, Rousseaux MW, Aleyasin H, Kamkar F, Callaghan S, Slack RS, Mak TW, Lee S, Figeys D, Park DS (2014b) Regulation of the VHL/HIF-1 pathway by DJ-1. J Neurosci 34(23):8043–8050. https://doi.org/10.1523/JNEUROSCI.1244-13.2014
Paterna JC, Leng A, Weber E, Feldon J, Bueler H (2007) DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther 15(4):698–704. https://doi.org/10.1038/sj.mt.6300067
Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7(2):97–110. https://doi.org/10.1016/j.drup.2004.01.004
Perier C, Bove J, Vila M, Przedborski S (2003) The rotenone model of Parkinson’s disease. Trends Neurosci 26(7):345–346. https://doi.org/10.1016/S0166-2236(03)00144-9
Raninga PV, Di Trapani G, Tonissen KF (2014) Cross talk between two antioxidant systems, Thioredoxin and DJ-1: consequences for cancer. Oncoscience 1(1):95–110. 10.18632/oncoscience.12
Raninga PV, Di Trapani G, Vuckovic S, Bhatia M, Tonissen KF (2015) Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma. Oncotarget 6(17):15410–15424. 10.18632/oncotarget.3795
Raninga PV, Di Trapani G, Vuckovic S, Tonissen KF (2016a) Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation. Apoptosis 21(12):1422–1437. https://doi.org/10.1007/s10495-016-1303-9
Raninga PV, Di Trapani G, Vuckovic S, Tonissen KF (2016b) TrxR1 Inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-kB inhibition. Cell Cycle 15:559–572. https://doi.org/10.1080/15384101.2015.1136038
Richardson JR, Quan Y, Sherer TB, Greenamyre JT, Miller GW (2005) Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 88(1):193–201. https://doi.org/10.1093/toxsci/kfi304
Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17(9):2596–2606. https://doi.org/10.1093/emboj/17.9.2596
Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson’s disease. Mov Disord 26(6):1049–1055. https://doi.org/10.1002/mds.23732
Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2(11):e362. https://doi.org/10.1371/journal.pbio.0020362
Shu K, Xiao Z, Long S, Yan J, Yu X, Zhu Q, Mei T (2013) Expression of DJ-1 in endometrial cancer: close correlation with Clinicopathological features and apoptosis. Int J Gynecol Cancer 23(6):1029–1035. https://doi.org/10.1097/IGC.0b013e3182959182
Song JJ, Lee YJ (2003) Role of the ASK1-SEK1-JNK1-HIPK1 signal in Daxx trafficking and ASK1 oligomerization. J Biol Chem 278(47):47245–47252. https://doi.org/10.1074/jbc.M213201200
Sulzer D, Surmeier DJ (2013) Neuronal vulnerability, pathogenesis, and Parkinson’s disease. Mov Disord 28(6):715–724. https://doi.org/10.1002/mds.25187
Sun SY, An CN, XP P (2012) DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats. Brain Res Bull 88(6):609–616. https://doi.org/10.1016/j.brainresbull.2012.05.013
Taira T, Takahashi K, Kitagawa R, Iguchi-Ariga SM, Ariga H (2001) Molecular cloning of human and mouse DJ-1 genes and identification of Sp1-dependent activation of the human DJ-1 promoter. Gene 263(1–2):285–292
Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5(2):213–218. https://doi.org/10.1038/sj.embor.7400074
Tang J, Liu J, Li X, Zhong Y, Zhong T, Liu Y, Wang JH, Jiang Y (2014) PRAK interacts with DJ-1 and prevents oxidative stress-induced cell death. Oxidative Med Cell Longev 2014:735618. https://doi.org/10.1155/2014/735618
Turoczi T, Chang VW, Engelman RM, Maulik N, Ho YS, Das DK (2003) Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol 35(6):695–704
Ueno M, Masutani H, Arai RJ, Yamauchi A, Hirota K, Sakai T, Inamoto T, Yamaoka Y, Yodoi J, Nikaido T (1999) Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274(50):35809–35815
Vasseur S, Afzal S, Tardivel-Lacombe J, Park DS, Iovanna JL, Mak TW (2009) DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses. Proc Natl Acad Sci U S A 106(4):1111–1116. https://doi.org/10.1073/pnas.0812745106
Waak J, Weber SS, Gorner K, Schall C, Ichijo H, Stehle T, Kahle PJ (2009) Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1. J Biol Chem 284(21):14245–14257. https://doi.org/10.1074/jbc.M806902200
Wang B, Qin H, Wang Y, Chen W, Luo J, Zhu X, Wen W, Lei W (2014) Effect of DJ-1 overexpression on the proliferation, apoptosis, invasion and migration of laryngeal squamous cell carcinoma SNU-46 cells through PI3K/AKT/mTOR. Oncol Rep 32(3):1108–1116. https://doi.org/10.3892/or.2014.3286
Wilson MA (2011) The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal 15(1):111–122. https://doi.org/10.1089/ars.2010.3481
Witt AC, Lakshminarasimhan M, Remington BC, Hasim S, Pozharski E, Wilson MA (2008) Cysteine pKa depression by a protonated glutamic acid in human DJ-1. Biochemistry 47(28):7430–7440. https://doi.org/10.1021/bi800282d
Yan YF, Chen HP, Huang XS, Qiu LY, Liao ZP, Huang QR (2015) DJ-1 mediates the delayed Cardioprotection of hypoxic preconditioning through activation of Nrf2 and subsequent upregulation of Antioxidative enzymes. J Cardiovasc Pharmacol 66(2):148–158. https://doi.org/10.1097/FJC.0000000000000257
Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, Mizusawa H (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 312(4):1342–1348
Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A 93(7):2696–2701
Yu HH, Xu Q, Chen HP, Wang S, Huang XS, Huang QR, He M (2013) Stable overexpression of DJ-1 protects H9c2 cells against oxidative stress under a hypoxia condition. Cell Biochem Funct. https://doi.org/10.1002/cbf.2949
Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, Montine TJ (1999) Parkinson’s Disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol 154(5):1423–1429. https://doi.org/10.1016/S0002-9440(10)65396-5
Zhang HY, Wang HQ, Liu HM, Guan Y, ZX D (2008) Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells. Endocr Relat Cancer 15(2):535–544. https://doi.org/10.1677/ERC-07-0195
Zhang M, Hou M, Ge L, Miao C, Zhang J, Jing X, Shi N, Chen T, Tang X (2014) Induction of peroxiredoxin 1 by hypoxia regulates heme oxygenase-1 via NF-kappaB in oral cancer. PLoS One 9(8):e105994. https://doi.org/10.1371/journal.pone.0105994
Zhou W, Freed CR (2005) DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J Biol Chem 280(52):43150–43158. https://doi.org/10.1074/jbc.M507124200
Zhou W, Zhu M, Wilson MA, Petsko GA, Fink AL (2006) The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol 356(4):1036–1048. https://doi.org/10.1016/j.jmb.2005.12.030
Zhu J, Chu CT (2010) Mitochondrial dysfunction in Parkinson’s disease. J Alzheimers Dis 20(Suppl 2):S325–S334. https://doi.org/10.3233/JAD-2010-100363
Zhu H, Liao SD, Shi JJ, Chang LL, Tong YG, Cao J, YY F, Chen XP, Ying MD, Yang B, He QJ, JJ L (2014) DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal. Free Radic Biol Med 71:121–132. https://doi.org/10.1016/j.freeradbiomed.2014.03.026
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Raninga, P.V., Di Trapani, G., Tonissen, K.F. (2017). The Multifaceted Roles of DJ-1 as an Antioxidant. In: Ariga, H., Iguchi-Ariga, S. (eds) DJ-1/PARK7 Protein. Advances in Experimental Medicine and Biology, vol 1037. Springer, Singapore. https://doi.org/10.1007/978-981-10-6583-5_6
Download citation
DOI: https://doi.org/10.1007/978-981-10-6583-5_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-6582-8
Online ISBN: 978-981-10-6583-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)